Jump to content

- - - - -

Mind & Matter podcast

  • Please log in to reply
No replies to this topic

#1 Cuboid



  • Black VIP
  • 859 posts

Posted 21 May 2022 - 05:31 AM

Thanks to @alanrockefeller for posting about this episode elsewhere online, one for geeking out about the psychopharmacology of tryptamine psychedelics and more:
"Nick talks to chemist & patent attorney Dr. Andrew Chadeayne, who is the CEO of the psychedelic startup CaaMTech. They discussed: the chemistry of magic mushrooms, including compounds beyond psilocybin, found in many species of psilocybin-containing mushrooms; the so-called entourage effect, the idea that multiple compounds found in plants and fungi might work together in a synergistic fashion to produce specific psychoactive or therapeutic effects; Cannabis and magic mushrooms; DMT, 5-MeO-DMT, and novel DMT analogues; how we went from academia, to patent law, to founding CaaMTech; the prospect of developing novel psychedelic drugs, non-hallucinogenic psychedelic drug analogues, and some of the details on how these various drugs differ in terms of their chemical structure."

Edited by Cuboid, 21 May 2022 - 05:35 AM.

  • bezevo likes this

Like Mycotopia? Become a member today!